Fiona Fang Capital Fund, with a scale of about US$ 4.4 billion, is currently one of the largest private equity investment funds focusing on the China market, and is committed to cooperating with leading private enterprises with development potential. Fiona Fang Capital has played an important role in many large and complicated investment cases in China market. Its long-term investment strategy focuses on the consumption upgrading and growth in China, and is aimed at those enterprises that benefit from the transformation of China's economic structure to consumption. Fiona Fang Capital is committed to building an industry leader together with the excellent management team of the invested enterprise. Investors in this fund include Canada National Pension Fund, Ontario Teachers Pension Fund and Singapore Temasek Holding Company.
On July 5th, 20021,Guichuang Tongqiao Medical Technology Co., Ltd. (hereinafter referred to as "Guichuang Tongqiao", stock code: 2 190), an enterprise invested by Fiona Fang capital and a market leader of China nerve and peripheral vascular interventional medical devices, was officially listed on the main board of the Hong Kong Stock Exchange, with an issue price of HK$ 42.70 per share. Guichuang Tongqiao closed at HK$ 60.00 per share on the first day, up 40.52% from the issue price, with a market value approaching HK$ 20 billion.
Mr. Zhang Hui, Managing Director of Fiona Fang Capital and Director of RMB Fund, said: "Combining Fiona Fang's many years of investment experience and PE investment strategy focusing on the middle and late stages, we have determined a set of selection criteria for investment targets: First, the founding team is experienced and entrepreneurial; Second, the company has a first-Mover advantage at the commercial level, and its products have been or have a high probability of obtaining regulatory approval; Third, the product portfolio is relatively complete, which can provide a complete set of programs for surgery; Fourth, it has a strong R&D capability, independent intellectual property rights of the underlying technology and a rich pipeline of self-developed products. Based on this standard, we found Guichuang Tongqiao, and finally we were lucky enough to invest in the leading enterprises in this segment. We hope to use Fiona Fang's many investment experiences and resources in the medical and health field to continue to firmly support the development of enterprises. "
About Fiona Fang Capital
Fiona Fang Capital is a leading market-oriented independent private equity investment institution in Asia, focusing on long-term investment in leading enterprises in the industry and working closely with the management team to help the invested enterprises in terms of strategy, operation, finance and capital market, so as to promote their growth and create outstanding value. Fiona Fang Capital has completed a series of successful landmark investments in Asia, Europe and the United States, with key investment areas including consumption, media and technology, medical and health care, industry, finance and enterprise services. . Investors of Fiona Fang Capital include the world's leading public pension funds, sovereign wealth funds and other institutional investors.